# Humana Inc: overview

HUM · NYSE · CIK 49071 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hum.md) · [Financials](/companies/hum/financials.md) · [Filings](/companies/hum/filings.md) · [Insiders](/companies/hum/insiders.md)

Latest reported revenue: [$39.65bn](/filings/0000049071-26-000023.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed Apr 29, 2026 (XBRL us-gaap:Revenues, accession 0000049071-26-000023).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [29.5](/filings/0000049071-25-000042.md) | [29.4](/filings/0000049071-25-000057.md) | [29.2 d](/filings/0000049071-26-000009.md) | [32.1](/filings/0000049071-26-000023.md) | [32.4](/filings/0000049071-25-000042.md) | [32.6](/filings/0000049071-25-000057.md) | [32.5 d](/filings/0000049071-26-000009.md) | [39.6](/filings/0000049071-26-000023.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [3.9%](/filings/0000049071-25-000042.md) | [2.5%](/filings/0000049071-25-000057.md) | [(1.9%) d](/filings/0000049071-26-000009.md) | [6.3%](/filings/0000049071-26-000023.md) | [3.4%](/filings/0000049071-25-000042.md) | [1.2%](/filings/0000049071-25-000057.md) | [(2.5%) d](/filings/0000049071-26-000009.md) | [4.4%](/filings/0000049071-26-000023.md) |
| Net margin | % | [2.3%](/filings/0000049071-25-000042.md) | [1.6%](/filings/0000049071-25-000057.md) | [(2.4%) d](/filings/0000049071-26-000009.md) | [3.9%](/filings/0000049071-26-000023.md) | [1.7%](/filings/0000049071-25-000042.md) | [0.6%](/filings/0000049071-25-000057.md) | [(2.4%) d](/filings/0000049071-26-000009.md) | [3.0%](/filings/0000049071-26-000023.md) |
| Diluted EPS | $ per share | [5.62](/filings/0000049071-25-000042.md) | [3.98](/filings/0000049071-25-000057.md) | not reported | [10.30](/filings/0000049071-26-000023.md) | [4.51](/filings/0000049071-25-000042.md) | [1.62](/filings/0000049071-25-000057.md) | not reported | [9.83](/filings/0000049071-26-000023.md) |
| Free cash flow | $bn | [1.1 d](/filings/0000049071-25-000042.md) | [1.7 d](/filings/0000049071-25-000057.md) | [(0.7) d](/filings/0000049071-26-000009.md) | [0.2](/filings/0000049071-26-000023.md) | [1.2 d](/filings/0000049071-25-000042.md) | [0.8 d](/filings/0000049071-25-000057.md) | [(1.9) d](/filings/0000049071-26-000009.md) | [1.1](/filings/0000049071-26-000023.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [83.1](/filings/0000049071-24-000012.md) | [92.9](/filings/0000049071-25-000007.md) | [106](/filings/0000049071-26-000009.md) | [118](/filings/0000049071-26-000009.md) | [130](/filings/0000049071-26-000009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [3.8%](/filings/0000049071-24-000012.md) | [4.1%](/filings/0000049071-25-000007.md) | [3.8%](/filings/0000049071-26-000009.md) | [2.2%](/filings/0000049071-26-000009.md) | [2.1%](/filings/0000049071-26-000009.md) |
| Net margin | % | [3.5%](/filings/0000049071-24-000012.md) | [3.0%](/filings/0000049071-25-000007.md) | [2.3%](/filings/0000049071-26-000009.md) | [1.0%](/filings/0000049071-26-000009.md) | [0.9%](/filings/0000049071-26-000009.md) |
| Diluted EPS | $ per share | [22.67](/filings/0000049071-24-000012.md) | [22.08](/filings/0000049071-25-000007.md) | [20.00](/filings/0000049071-26-000009.md) | [9.98](/filings/0000049071-26-000009.md) | [9.84](/filings/0000049071-26-000009.md) |
| Free cash flow | $bn | [0.9](/filings/0000049071-24-000012.md) | [3.5](/filings/0000049071-25-000007.md) | [3.0](/filings/0000049071-26-000009.md) | [2.4](/filings/0000049071-26-000009.md) | [0.4](/filings/0000049071-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hum/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $4.35bn | 10,940,380 |  | Reduced −440,293 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.14bn | 10,417,803 |  | Added +218,748 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.12bn | 7,843,620 |  | Added +4,858 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.31bn | 5,818,956 |  | Added +10,521 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.17bn | 5,457,072 |  | Added +4,080 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $1.75bn | 4,403,136 |  | Reduced −1,067,846 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $1.66bn | 3,578,245 |  | Reduced −904,125 |
| [EAGLE CAPITAL MANAGEMENT LLC](/funds/945631.md) | 2026-06-30 | $1.53bn | 3,846,762 |  | Added +879,688 |
| [Sessa Capital IM, L.P.](/funds/1595849.md) | 2026-06-30 | $1.48bn | 3,727,740 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.34bn | 3,369,757 |  | Added +43,062 |

## Recent filings

[All 2,268 filings](/companies/hum/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 10:04 ET | [8-K](/filings/0000049071-26-000060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000049071-26-000060 |
| 2026-10-09 | 10:01 ET | [8-K](/filings/0000049071-26-000057.md) | 7.01 Regulation FD disclosure | 0000049071-26-000057 |
| 2026-09-01 | 11:30 ET | [8-K](/filings/0000049071-26-000052.md) | 7.01 Regulation FD disclosure | 0000049071-26-000052 |
| 2026-07-29 | 18:11 ET | [10-Q](/filings/0000049071-26-000050.md) | Quarterly report, period 2026-06-30 | 0000049071-26-000050 |
| 2026-07-29 | 11:00 ET | [8-K](/filings/0000049071-26-000047.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000049071-26-000047 |
| 2026-07-29 | 10:19 ET | [8-K](/filings/0000049071-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000049071-26-000045 |
| 2026-06-01 | 10:37 ET | [8-K](/filings/0000049071-26-000027.md) | 7.01 Regulation FD disclosure | 0000049071-26-000027 |
| 2026-05-19 | 20:30 ET | [8-K](/filings/0000049071-26-000025.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000049071-26-000025 |
| 2026-04-29 | 18:09 ET | [10-Q](/filings/0000049071-26-000023.md) | Quarterly report, period 2026-03-31 | 0000049071-26-000023 |
| 2026-04-29 | 10:06 ET | [8-K](/filings/0000049071-26-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000049071-26-000021 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000049071-26-000009.md), filed Feb 19, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 49071
- Tickers: HUM
- Exchange: NYSE
- SIC code: 6324 Hospital & Medical Service Plans
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.